Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles

Article Link: Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles



Source: FDA New Drug Approvals